Apyx Medical to Present at BTIG MedTech Conference
Event summary
- Apyx Medical to participate in BTIG 13th Annual MedTech Conference on February 10, 2026.
- Company focuses on surgical aesthetics with Renuvion and AYON Body Contouring System.
- Over 90 clinical documents support effectiveness of Renuvion and J-Plasma technologies.
- AYON system integrates fat removal, contouring, and tissue contraction capabilities.
The big picture
Apyx Medical's participation in the BTIG MedTech Conference underscores its strategic focus on expanding its footprint in the surgical aesthetics market. The company's innovative products, particularly the AYON Body Contouring System, position it to capitalize on the growing demand for minimally invasive cosmetic procedures. The conference provides a platform to showcase its technological advancements and clinical validation to potential investors and partners.
What we're watching
- Market Positioning
- How Apyx Medical will leverage conference exposure to strengthen its position in the surgical aesthetics market.
- Product Adoption
- The pace at which AYON Body Contouring System gains traction among surgeons and patients.
- Clinical Validation
- Whether the growing number of clinical documents will translate into increased market confidence and adoption.
Our editorial coverage: